share_log

HC Wainwright & Co. Maintains Buy on Akero Therapeutics, Raises Price Target to $50

HC Wainwright & Co. Maintains Buy on Akero Therapeutics, Raises Price Target to $50

HC Wainwright & Co.维持对Akero Therapeutics的买入,将目标股价上调至50美元
Benzinga ·  03/05 06:46

HC Wainwright & Co. analyst Ed Arce maintains Akero Therapeutics (NASDAQ:AKRO) with a Buy and raises the price target from $43 to $50.

HC Wainwright & Co. 分析师埃德·阿尔塞维持Akero Therapeutics(纳斯达克股票代码:AKRO)的买入并将目标股价从43美元上调至50美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发